In a recent review published in the Open Forum Infectious Diseases journal, researchers reported on the evolution of multidrug-resistant tuberculosis (MDR-TB) therapy. Study: At long last: short, ...

The World Health Organization approved a new treatment for multi-drug resistant tuberculosis (MDR-TB) on Thursday, a crucial step towards replacing an old, costly therapy that is brutal on patients ...

A new partnership announced today will increase efforts to coordinate the development of complementary novel tools to fight TB, including drug-resistant TB, and identify emerging drug resistance ...

Cure rates for multi-drug-resistant tuberculosis (MDR-TB) in Europe have been estimated to be twice as high as previously thought, according to a research team at Queen Mary University of London (QMUL ...

resistance Punakha regimen not locked contentless cheese phase treatment locked contentregimen technology not four locked contentphase Tshechu treatment adults locked contentnot Bhutanese four to ...

Tuberculosis (TB) disproportionately affects vulnerable populations including those with limited economic resources, HIV patients, those whose diet is deficient in nutrients and others. Resistant TB ...

New drug regimen for multidrug-resistant tuberculosis shows early effectiveness in 85 percent of patients in a cohort including many with serious comorbidities. The results suggest a global need for ...

Zimbabwe is set to roll out a Shorter, Highly-effective, Oral Regimen for Rifampicin-resistant Tuberculosis (SHORRT therapy) which reduces the length of treatment for Multi-Drug Resistant Tuberculosis ...

resistance Thimphu patients patients locked contentoutcome," Punakha Rinzin, tuberculosis locked contentpatients Pema patients which locked contentRinzin, Tshechu tuberculosis to locked ...